DK0536197T3 - Ren, krystallinsk form af rifapentine - Google Patents

Ren, krystallinsk form af rifapentine

Info

Publication number
DK0536197T3
DK0536197T3 DK91911451.2T DK91911451T DK0536197T3 DK 0536197 T3 DK0536197 T3 DK 0536197T3 DK 91911451 T DK91911451 T DK 91911451T DK 0536197 T3 DK0536197 T3 DK 0536197T3
Authority
DK
Denmark
Prior art keywords
crystalline form
rifapentine
pure
pure crystalline
new pure
Prior art date
Application number
DK91911451.2T
Other languages
Danish (da)
English (en)
Inventor
Bruno Cavalleri
Marino Nebuloni
Emilio Occelli
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Application granted granted Critical
Publication of DK0536197T3 publication Critical patent/DK0536197T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08—Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyridine Compounds (AREA)
  • Medicinal Preparation (AREA)
DK91911451.2T 1990-06-29 1991-06-05 Ren, krystallinsk form af rifapentine DK0536197T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP90112458 1990-06-29

Publications (1)

Publication Number Publication Date
DK0536197T3 true DK0536197T3 (da) 1995-11-13

Family

ID=8204159

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91911451.2T DK0536197T3 (da) 1990-06-29 1991-06-05 Ren, krystallinsk form af rifapentine

Country Status (13)

Country Link
EP (1) EP0536197B1 (de)
JP (1) JP3350861B2 (de)
KR (1) KR0170000B1 (de)
AT (1) ATE125541T1 (de)
BG (1) BG60980B2 (de)
CA (1) CA2082809C (de)
DE (1) DE69111607T2 (de)
DK (1) DK0536197T3 (de)
ES (1) ES2075454T3 (de)
HK (1) HK1005454A1 (de)
HU (1) HU211168A9 (de)
IE (1) IE68687B1 (de)
WO (1) WO1992000302A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1279898B1 (de) 2001-07-26 2008-09-10 ALSTOM Technology Ltd Vormischbrenner mit hoher Flammenstabilität
ITMI20032144A1 (it) * 2003-11-07 2005-05-08 Alfa Wassermann Spa Forme polimorfe di rifaximina, processi per ottenerle e
US7262236B2 (en) 2004-04-26 2007-08-28 Milliken & Company Acetal-based compositions
PL1698630T3 (pl) 2005-03-03 2014-12-31 Alfasigma Spa Nowe postacie polimorficzne rifaksyminy,sposoby ich wytwarzania i ich zastosowanie w preparatach leczniczych
IT1397107B1 (it) * 2009-12-28 2012-12-28 Lavagna Nuovo metodo per la preparazione di antibiotici in stato amorfo e prodotti ottenuti utilizzando detto metodo.
EP2401282B2 (de) 2009-12-28 2017-01-04 Silvio Massimo Lavagna Verfahren zur herstellung von amorphem rifaximin
IT1398550B1 (it) 2010-03-05 2013-03-01 Alfa Wassermann Spa Formulazioni comprendenti rifaximina utili per ottenere un effetto prolungato nel tempo
CN102079749B (zh) * 2010-11-25 2012-07-04 河北欣港药业有限公司 利福平原料药≤0.3g/ml及≥0.8g/ml密度规格的生产方法
ITBO20120368A1 (it) 2012-07-06 2014-01-07 Alfa Wassermann Spa Composizioni comprendenti rifaximina e amminoacidi, cristalli di rifaximina derivanti da tali composizioni e loro uso.
CN103772413B (zh) * 2014-02-07 2016-01-20 天津大学 一种利福平ⅱ晶型的制备方法
US20240199642A1 (en) * 2021-04-21 2024-06-20 Interquim S.A. De C.V. Method for obtaining rifapentine with a new crystalline form

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1478563A (en) * 1975-03-05 1977-07-06 Lepetit Spa Rifamycin derivatives
GB8816620D0 (en) * 1988-07-13 1988-08-17 Lepetit Spa Rifapentine hydrohalides

Also Published As

Publication number Publication date
ES2075454T3 (es) 1995-10-01
JPH05507690A (ja) 1993-11-04
WO1992000302A1 (en) 1992-01-09
EP0536197B1 (de) 1995-07-26
JP3350861B2 (ja) 2002-11-25
EP0536197A1 (de) 1993-04-14
HU211168A9 (en) 1995-11-28
KR0170000B1 (ko) 1999-02-01
HK1005454A1 (en) 1999-01-08
DE69111607T2 (de) 1995-12-21
KR930701448A (ko) 1993-06-11
DE69111607D1 (de) 1995-08-31
CA2082809C (en) 1995-10-17
ATE125541T1 (de) 1995-08-15
BG60980B2 (bg) 1996-07-31
IE912266A1 (en) 1992-01-01
IE68687B1 (en) 1996-07-10

Similar Documents

Publication Publication Date Title
NZ240230A (en) Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof
MA22842A1 (fr) Procede de preparation de compositions de vaccin.
FI931708A0 (fi) Herbicida substituerade aryl-haloalkylpyrazoler
FI931031A (fi) Mometasonfuroatmonohydrat, foerfarande foer dess framstaellning och farmaceutiska sammansaettningar
DK0629608T3 (da) Fremgangsmåde til fremstilling af N-acyl-N,N',N'-ethylendiamintrieddikesyrederivater
GB2210879B (en) 4h-1-benzopyran-4-one derivative or its salt, process for producing the same and pharmaceutical composition comprising the same as active ingredient
SE8700499D0 (sv) Novel pharmacologically active compounds
ES2128519T3 (es) Nuevas pirido-tiadiazinas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
DK0458699T3 (da) Anvendelse af baclofen til fremstilling af lægemidler til behandling af angina pectoris
RU93004445A (ru) Новые 2-циано 3-гидроксиенамидные производные, способ их получения, их применение в качестве медикаментов, содержащие их фармацевтические композиции и новые полученные промежуточные продукты
DK0536197T3 (da) Ren, krystallinsk form af rifapentine
GR1001597B (el) Νέα βιολογικώς δραστικά παράγωγα εμπουρναμενίνης, φαρμακευτικές συν?έσεις οι οποίες περιέχουν αυτά και μέ?οδος δια την παρασκευή αυτών.
DK0750616T3 (da) Syreadditionssalte af 2,3,4,5-tetrahydro-1H-3-benzazapinforbindelser
ITRM910430A1 (it) Composizioni farmaceutiche di somatostatina con assorbimento migliorato, loro preparazione e loro impiego
IT1290797B1 (it) Composizioni farmaceutiche stabilizzate
DK0487319T3 (da) Hidtil ukendt heptamethylindanforbindelse
DK0625153T3 (da) Nyt isoindolinonderivat, dets fremstilling og farmaceutiske præparater med et indhold deraf
MX9203732A (es) R-enentiomeros de compuestos de n-propargil-1-aminoindan, su preparacion y composiciones farmaceuticas que contienen los mismos.
FR2601021B2 (fr) Fraction immunogene active a l'egard des bilharzioses, sa preparation, compositions immunisantes la contenant
FI903701A0 (fi) Reninhaemmande amino-oligohydroxiderivat.
FI870994A0 (fi) Foerfarande foer framstaellning av stabila, injekterbara farmaceutiska kompositioner, vilka innehaoller 1,4-dihydroxi-5,8-bis/2-(2-hydroxietylamino)etylamino/ antrakinondihydroklorid.
DE69614552D1 (de) MODIFIZIERTE ALPHA-D-GLCP-(1,2)-ALPHA-D-Glcp-(1,3)-ALPHA-D-Glcp-ANALOGE
SE9203824D0 (sv) Benzofuranylimidazole derivatives a process for the preparation and therapeutical compositions containing the same
DK0427160T3 (da) Benzylselenobenzamid af aminopyridiner og picolylaminer
MX9202293A (es) Composicion de vacuna no-irritante.